Cash flows from operating activities: | |
Net loss | |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |
Accrued interest expense | 6.34M |
Amortization of debt issuance costs | |
Depreciation and amortization | 10.84M |
Impairment loss on intangible assets and equipment | |
Provision for bad debts | 96K |
Net impairment loss on marketable securities | |
Inventory provision | 2.58M |
Share-based compensation expense | 3.44M |
Excess tax benefits from equity based compensation | |
Non-cash income tax expense (benefit) | -735K |
Changes in assets and liabilities: | |
Accounts receivable | 9.88M |
Inventories | 3.76M |
Prepaid expenses and other assets | -6.19M |
Accounts payable | -7.08M |
Accrued expenses, income taxes, and other | |
Net cash provided by (used in) operating activities | 51K |
Cash flows from investing activities: | |
Purchases of property and equipment | -875K |
Purchases of intangible assets | -2.09M |
Purchases of securities | |
Securities maturities/sales | |
Net cash provided by investing activities | 6.19M |
Cash flows from financing activities: | |
Proceeds from the issuance of short-term debt, net of issuance costs | |
Principal payments under capital lease obligations | -722K |
Proceeds from stock option exercises net of taxes paid on vested restricted stock units | |
Excess tax benefits from equity based compensation | |
Deposit of restricted funds | |
Net cash used in financing activities | -1.49M |
Effect of exchange rates on cash and cash equivalents | -147K |
Net increase (decrease) in cash and cash equivalents | 4.6M |
Cash and cash equivalents, beginning of period | 12.57M |
Cash and cash equivalents, end of period | 17.17M |
Supplemental disclosures of cash flow information: | |
Interest | |
Income taxes | |
Supplemental disclosures of non-cash financing activities: | |
Marketable equity securities received in settlement of note receivable | |
Accrued debt issuance costs |